Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Linda Aagaard Rasmussen, Niels Lyhne Christensen, Anne Winther-Larsen, Susanne Oksbjerg Dalton, Line Flytkjær Virgilsen, Henry Jensen & Peter Vedsted. (2023) A Validated Register-Based Algorithm to Identify Patients Diagnosed with Recurrence of Surgically Treated Stage I Lung Cancer in Denmark. Clinical Epidemiology 15, pages 251-261.
Read now
Read now
A. Gouliaev, T. R. Rasmussen, N. Malila, L. Fjellbirkeland, L. Löfling, E. Jakobsen, S. O. Dalton & N. L. Christensen. (2023) Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization. Acta Oncologica 62:1, pages 1-7.
Read now
Read now
Therkildsen Ditte Skadhede, Christensen Jane, Andersen Ole, Thomsen Linda Aagaard, Rasmussen Torben Riis & Christensen Niels Lyhne. (2021) Outcomes and characteristics of Danish patients undergoing a lung cancer patient pathway without getting a lung cancer diagnosis. A retrospective cohort study. European Clinical Respiratory Journal 8:1.
Read now
Read now
Frida E. Lundberg, Therese M.-L. Andersson, Mats Lambe, Gerda Engholm, Lina Steinrud Mørch, Tom Børge Johannesen, Anni Virtanen, David Pettersson, Elínborg J. Ólafsdóttir, Helgi Birgisson, Anna L. V. Johansson & Paul C. Lambert. (2020) Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies. Acta Oncologica 59:11, pages 1266-1274.
Read now
Read now
Virve Alanen & Jussi P. Koivunen. (2019) Association of diagnostic delays to survival in lung cancer: single center experience. Acta Oncologica 58:7, pages 1056-1061.
Read now
Read now
Niels Lyhne Christensen, Susanne Oksbjerg Dalton, Anders Mellemgaard, Jane Christensen, Anne Mette Tranberg Kejs & Torben Riis Rasmussen. (2018) Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence?. Acta Oncologica 57:11, pages 1556-1560.
Read now
Read now
Articles from other publishers (20)
Marnar Fríðheim Kristiansen, Ronja Midjord Mikkelsen, Tordis Kristiansdóttir, Guðrið Andórsdóttir, Sæunn Ólavsdóttir Hansen, Bjarni á Steig, Kári Rubek Nielsen, Maria Skaalum Petersen & Marin Strøm. (2023) Cancer survival in the Faroe Islands over the last 50 years compared to the other Nordic countries. International Journal of Cancer 152:10, pages 2090-2098.
Crossref
Crossref
Inger Johanne Zwicky Eide, Yngvar Nilssen, Elin Marie Stensland & Odd Terje Brustugun. (2023) Real-World Data on EGFR and ALK Testing and TKI Usage in Norway—A Nation-Wide Population Study. Cancers 15:5, pages 1505.
Crossref
Crossref
Maria Iachina, Pavithra Laxsen Anru & Erik Jakobsen. (2023) Effects of Demographic and Socio-Economic Factors on Investigation Time of Lung Cancer Patients in Denmark: A Retrospective Cohort Study. Health Services Research and Managerial Epidemiology 10.
Crossref
Crossref
Rike Geiken-Weinstock, Anna K.L. Reyners, Frank Griesinger, Burkhard Joerg Otremba, Michael Hoheisel & Jörg Bäsecke. (2023) Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study. Oncology Research and Treatment 46:6, pages 227-235.
Crossref
Crossref
Lisa Maria Sele Sætre, Sanne Rasmussen, Kirubakaran Balasubramaniam, Jens Søndergaard & Dorte Ejg Jarbøl. (2022) A population-based study on social inequality and barriers to healthcare-seeking with lung cancer symptoms. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Jonatan Lindqvist, Antti Jekunen, Eero Sihvo, Mikael Johansson & Heidi Andersén. (2022) Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients. Lung Cancer 171, pages 9-17.
Crossref
Crossref
Jianrong Zhang, Maarten J. IJzerman, Jasmeen Oberoi, Napin Karnchanachari, Rebecca J. Bergin, Fanny Franchini, Paige Druce, Xiaofei Wang & Jon D. Emery. (2022) Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer 166, pages 27-39.
Crossref
Crossref
Luv Khandelwal, Housne Begum & Pria Nippak. (2022) The Impact of Delays during the Pandemic Months on Survival of Lung Cancer Patients in Canada in 2020. Open Journal of Epidemiology 12:03, pages 261-273.
Crossref
Crossref
Charlotte Lynch, Samantha Harrison, John Butler, David R. Baldwin, Paul Dawkins, Joris van der Horst, Erik Jakobsen, Jonathan McAleese, Annette McWilliams, Karen Redmond, Anand Swaminath & Christian J. Finley. (2022) An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership. Cancer Control 29, pages 107327482211193.
Crossref
Crossref
Åslaug Helland, Klaus Kaae Andersen, Tor Åge Myklebust, Tom Børge Johannesen, Jørgen Aarøe & Espen Enerly. (2022) EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway – A nationwide retrospective cohort study. Cancer Treatment and Research Communications 33, pages 100636.
Crossref
Crossref
Syaribah Noor Brice, Paul Harper, Tom Crosby, Daniel Gartner, Edilson Arruda, Tracey England, Emma Aspland & Kieran Foley. (2021) Factors influencing the delivery of cancer pathways: a summary of the literature. Journal of Health Organization and Management 35:9, pages 121-139.
Crossref
Crossref
Adnan Ansar, Virginia Lewis, Christine Faye McDonald, Chaojie Liu & Muhammad Aziz Rahman. (2021) Duration of intervals in the care seeking pathway for lung cancer in Bangladesh: A journey from symptoms triggering consultation to receipt of treatment. PLOS ONE 16:9, pages e0257301.
Crossref
Crossref
Jean-Baptiste Leclère, Ludovic Fournel, Harry Etienne, Charbel Al Zreibi, Ilaria Onorati, Arnaud Roussel, Yves Castier, Emmanuel Martinod, Françoise Le Pimpec-Barthes, Marco Alifano, Jalal Assouad & Pierre Mordant. (2021) Maintaining Surgical Treatment of Non-Small Cell Lung Cancer During the COVID-19 Pandemic in Paris. The Annals of Thoracic Surgery 111:5, pages 1682-1688.
Crossref
Crossref
Anthony Brade, Kevin Jao, Simon Yu, Parneet Cheema, Sarah Doucette, Anna Christofides & Devin Schellenberg. (2021) A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer. Current Oncology 28:3, pages 1618-1629.
Crossref
Crossref
John Milkovich, Tim Hanna, Carolyn Nessim, Teresa M. Petrella, Louis Weatherhead, An-Wen Chan, Jonathan C. Irish, Christian Murray, Grace Bannerman, Claire Holloway, Katharina Forster, Laura Pazzano & Frances C. Wright. (2021) Restructuring Skin Cancer Care in Ontario: A Provincial Plan. Current Oncology 28:2, pages 1183-1196.
Crossref
Crossref
Astrid Kravdal, Øystein Olav Stubhaug, Anne Grete Wågø, Magnus Steien Sætereng, Dag Amundsen, Ruta Piekuviene & Annette Kristiansen. (2020) Pulmonary tularaemia: a differential diagnosis to lung cancer. ERJ Open Research 6:2, pages 00093-2019.
Crossref
Crossref
Martti Arffman, Kristiina Manderbacka, Jaana Suvisaari, Jussi Koivunen, Sonja Lumme, Ilmo Keskimäki, Aulikki Ahlgren-Rimpiläinen & Eero Pukkala. (2019) The impact of severe mental illness on lung cancer mortality of patients with lung cancer in Finland in 1990–2013: a register-based cohort study. European Journal of Cancer 118, pages 105-111.
Crossref
Crossref
Bryan S. Benn, Mihir Parikh, Pei H. Tsau, Eric Seeley & Ganesh Krishna. (2019) Using a Dedicated Interventional Pulmonology Practice Decreases Wait Time Before Treatment Initiation for New Lung Cancer Diagnoses. Lung 197:2, pages 249-255.
Crossref
Crossref
Niels Lyhne Christensen, Anders Løkke, Susanne Oksbjerg Dalton, Jane Christensen & Torben Riis Rasmussen. (2018) Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients. Lung Cancer 124, pages 40-44.
Crossref
Crossref
Odd Terje Brustugun, Bjørn Henning Grønberg, Lars Fjellbirkeland, Nina Helbekkmo, Marianne Aanerud, Tom Kristian Grimsrud, Åslaug Helland, Bjørn Møller, Yngvar Nilssen, Trond Eirik Strand & Steinar Kristian Solberg. (2018) Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer 122, pages 138-145.
Crossref
Crossref